Cargando…
Serum Biomarker Status with a Distinctive Pattern in Prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma
OBJECTIVE: Gastroenteropancreatic neuroendocrine carcinoma (GEPNEC) is a major research focus, but the application of biomarkers to guide its prognostication and management is unsatisfying. Clinical values of conventional serum biomarkers, neuron-specific enolase (NSE), carcinoembryonic antigen (CEA...
Autores principales: | Zhang, Jianwei, Cao, Yanshuo, Zhang, Panpan, Zhang, Xiaotian, Li, Jian, Zhou, Jun, Wang, Xicheng, Peng, Zhi, Sun, Yu, Li, Jie, Shen, Lin, Lu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533446/ https://www.ncbi.nlm.nih.gov/pubmed/34592743 http://dx.doi.org/10.1159/000519948 |
Ejemplares similares
-
Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine‐non‐neuroendocrine neoplasm
por: Zhang, Panpan, et al.
Publicado: (2021) -
Psychological distress and resilience in patients with gastroenteropancreatic neuroendocrine tumor
por: Song, Lili, et al.
Publicado: (2022) -
Etoposide and cisplatin versus irinotecan and cisplatin as the first‐line therapy for patients with advanced, poorly differentiated gastroenteropancreatic neuroendocrine carcinoma: A randomized phase 2 study
por: Zhang, Panpan, et al.
Publicado: (2020) -
Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm
por: Wang, Yuhong, et al.
Publicado: (2018) -
Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors
por: Sansone, Andrea, et al.
Publicado: (2019)